Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

NCT04413734 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma by AJCC V8 Stage

Interventions

DRUG: Combination therapy
DRUG: Mono-chemotherapy

Sponsor

Zhejiang University